Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Cancer Research|June 25, 2009
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomasIsabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, et al.
Oncoimmunology|July 4, 2012
Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patientsManuarii Manuel, Olivier Tredan, Thomas Bachelot, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETOJean-Yves Blay, Nicolas Penel, Maud Toulmonde, et al.
Oncotarget|August 29, 2015
The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic valueXiaojun Jiang, Daniel Pissaloux, Christelle De La Fouchardiere, et al.
JCO Precision Oncology|January 20, 2022
Tumor Molecular Profiling: Pediatric Results of the ProfiLER StudySarah Benezech, Pierre Saintigny, Valery Attignon, et al.
The Lancet. Oncology|August 10, 2024
Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trialJean-Yves Blay, Quentin Devin, Florence Duffaud, et al.
Anticancer Research|July 5, 2020
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC StudyPierre Heudel, Suzette Delaloge, Damien Parent, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2018
Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohortElisa Gobbini, Monia Ezzalfani, Véronique Dieras, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2020
Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016Elise Deluche, Alison Antoine, Thomas Bachelot, et al.
Nature|August 2, 2023
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancerPhilippe A Cassier, Raul Navaridas, Melanie Bellina, et al.
Pageof 6